DoW Neurofibromatosis Research Academy – Scholar Award
Defense Health Agency Contracting Activity - DHACA · Department of Defense
At a glance
DoW Neurofibromatosis Research Academy – Scholar Award is a closed federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). The application deadline was September 22, 2026. Total estimated funding is $3.6M across about 3 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Jun 25, 2026Posted
- Sep 22, 2026Application deadline
- Oct 22, 2026Archivednext date
- Posted
- Jun 25, 2026
- Close date
- Sep 22, 2026
- Archive date
- Oct 22, 2026
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- $3,600,000
- Implied average award
- $1,200,000 calculated
- Expected awards
- 3
- Cost sharing
- Not required
- Funding instrument
- Grant
- Opportunity category
- Discretionary
Typical awards for this program (SAM.gov listing for ALN 12.420, not this notice): This Assistance Listing supports approximately 30 or more programs each year. Overall, awards are expected to range from $100,000 to $20M (consortium) depending on the funding priorities, anticipated number of awards, and project activity/scope within each program for an award period, on average, of 3 to 4 years. The maximum award amount, if any, is specified in each Program Announcement or Broad Agency Announcement.
Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.
Who can apply
- Unrestricted (any entity type)
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Scholar Award (NFRA-SA) supports early-career independent investigators (Scholars) joining the Neurofibromatosis Research Academy to pursue a neurofibromatosis project that may include basic, translational, and/or clinical research. The proposed research should address at least one of the FY26 NFRP Areas of Emphasis, under the leadership of the NFRA Director and Deputy Director. The overarching goal of the NFRA is to conduct innovative and impactful research in the field of neurofibromatosis disorders while developing successful, highly productive NF researchers in a collaborative research and career development environment.
Distinctive Features:
• Scholar: The Scholar, named as the Principal Investigator, must be less than 10 years of completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave).
• Career Guide: This award mechanism requires each Scholar to designate a Career Guide for guidance. The Career Guide is not required to be at the same institution as the Scholar; however, if the (primary) Career Guide is from a different institution, the application must identify a secondary Career Guide at the Scholar’s institution.
Full announcement & documents
The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.
Assistance Listing
What is an ALN?Reported obligations under ALN 12.420
Historical data · not a predictionAgency contact (as published)
Ebony S Simmons Grantor
help@eBRAP.org
301-619-2105
Quick answers
Who is eligible to apply for “DoW Neurofibromatosis Research Academy – Scholar Award”?
The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.
How much funding is available through “DoW Neurofibromatosis Research Academy – Scholar Award”?
Per the notice, total estimated program funding is $3,600,000 and the agency expects to make about 3 awards.
How do I apply for “DoW Neurofibromatosis Research Academy – Scholar Award”?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942526NFRPNFRASA), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
DoW Melanoma Research Program Melanoma Academy Scholar Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 14, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Melanoma Research Program Focused Program Award – Rare Melanomas
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 14, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Traumatic Brain Injury and Psychological Health, Health Services Research Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 15, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Traumatic Brain Injury and Psychological Health, Translational Research Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 15, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Arthritis Translational Research Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 22, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Joint Warfighter Medical, Military Medical Research and Development Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Nov 16, 2026
- Who can apply
- Unrestricted (any entity type)